creating together with residues located in helices 3, 5 and 6 a surface that facilitates coactivator interactions (5,6). A signature LXXLL motif in the coactivator proteins mediates association with receptors LBDs (7, 8) . Coactivators form large complexes, which act as chromatin remodelers through intrinsic histone acetylase activity (3). In addition other complexes appear to act more directly on the transcriptional apparatus, suggesting that activation of gene expression by the receptors involves both chromatin modifications and direct recruitment of basal transcription factors to the regulated promoter (2). Transcriptional silencing by corepressor complexes also involves changes in histone acetylation. The corepressors SMRT (silencing mediator for retinoid and thyroid hormone receptors) (9) and NCoR (nuclear receptor corepressor) (10) assemble in complexes that include histone deacetylases (HDACs). The corepressors can interact indirectly with class I HDACs through the Sin3 protein (11-13), and directly with class II HDACs through a different domain (14, 15) . Recruitment of deacetylases is believed to cause chromatin compactation and transcriptional repression.
EXPERIMENTAL PROCEDURES
Plasmids-The constructs -39GH-CAT, -145GH-CAT and -530GH-CAT containing 5´-flanking sequence of the rat GH promoter cloned into the polylinker region of the pUC8 vector in which an AP-1 site has been deleted, and TATA-CAT containing a consensus TATA box in the same vector have been described (19) . -530mutGH-CAT was generated with the QuickChange TM site-directed mutagenesis kit (Stratagene) with the oligonucleotide 5´-GGAAAACCGGTTGGGTATAAAACGGGTATGCAAGGG-3´. This mutation removes the proximal nTRE located between nucleotides -34 and -18. Expression vectors for TRα and TRβ contain the cDNA sequences of α chick TR and the β isoform of human TRβ, respectively.
Chimeras between v-erbA and TRα, as well expression vectors for the mutants chick TRα E401/Q, E401/K, and K232/I were previously described (4, 32) . In the AHT receptor 3 residues in helix 1 of the LBD of TRβ have been mutated (10) . In the TRα mutant C51G, a conserved cysteine residue was substituted by a glycine residue by site-directed mutagenesis. This mutant receptor does not bind DNA and was a gift from A.Pascual. Expression vectors for TBP and the nuclear receptor corepressor (NCoR) (12, 28) were also used.
Cell culture, transient transfections, and CAT assays-HeLa cells were cultured in DMEM
containing 10% fetal calf serum and transfected with calcium phosphate with 5 µg of the reporter plasmid as previously described (19) Mobility assay conditions were optimized for simultaneous binding of the receptors and TBP. For this purpose the poly (dI-dC) was replaced by poly (dG-dC) and 10 mM MgCl 2 was used in the binding buffer. For the binding assays the purified proteins were incubated on ice for 15 min. in a buffer (10 mM Hepes pH=8.4, 90 mM KCl, 1mM dithiothreitol, 5 µg/ml bovine serum albumin, 10% glycerol) containing 500 ng poly(dG.dC) and then for 20-30 min at room temperature with approximately 30,000 cpm double-stranded oligonucleotide end-labeled with [γ-32 P]ATP using T4-polynucleotide kinase. DNA-protein complexes were resolved on 5% polyacrylamide gels in 0.5X TBE buffer. The gels were then dried and autoradiographed. . TBP and TBP deletions mutants fused to GST (35) were expressed in the bacterial strain BL21 (DE3). They were grown at 37ºC in LB until the absorbance reached 0.6. Then the induction was performed at 30ºC for 2h with 0.4 mM isopropyl b-D-thiogalactopyranoside (IPTG). GST and GST fusion proteins were purified by standard techniques following the recommendations of Pharmacia. The expression of correctly sized proteins was monitored by SDS-PAGE. GST-pull down assays were performed with 5 µl of the in vitro translated L- [ 35 S ]methionine-labeled receptors as described previously (36) . These proteins were incubated with 1 µg of the GST-fusion protein, or with the same amount of GST as a control, immobilized in glutathione-sepharose beads. 
Protein-protein interactions-

RESULTS
Binding to the nTRE is required for regulation of GH promoter activity by TR-In non-pituitary
HeLa cells, which express low TR levels, treatment with T3 did not affect the activity of a reporter plasmid containing the fragment -530 to +8 of the GH promoter. However, and in agreement with our previous observations (19) , when this plasmid was transfected along with an expression vector for TRα, a ligand-independent stimulation of transcription, which was reversed by T3 was observed (Fig.1A) . To analyze the contribution of the positive TRE located at -167/-190 and the nTRE that overlaps the TATA box to this regulation, a plasmid in which the proximal element was mutated was also used. Interestingly, TR stimulated only weakly activity of the mutated promoter, suggesting that the proximal element is mostly responsible for the observed regulation.
This was confirmed with the construct -145GH-CAT, which contains only the nTRE, which was induced by the unliganded receptor and repressed by T3 to a similar extent as the plasmid containing both DNA elements. To analyze whether binding to DNA was required for activation of the minimal GH promoter, the influence of a TRα mutant in a cysteine of the first zinc finger of the DNA binding domain (DBD) was also analyzed. As illustrated in Fig.1B , whereas the unliganded wild type receptor significantly increased basal promoter activity, the mutant receptor C51G that does not bind DNA was unable to increase CAT activity. As a consequence, a liganddependent repression was not either observed. These results indicate that binding of the receptor to the nTRE is necessary for ligand-independent stimulation, as well as for negative regulation by
T3.
In vivo binding of TR to the GH promoter. Chromatin immunoprecipitation assays with an anti-9
TRα antibody were performed in HeLa cells transfected with different GH promoter plasmids. As shown in Fig.2 , upon expression of TRα, a significant binding to the construct that contains both TREs was found. Promoter occupancy by the receptor paralleled transcriptional activity and, accordingly, TRα binding to the promoter was reversed by T3. In addition, no binding of the receptor to the promoter fragment in which the nTRE has been mutated was observed. This is also in agreement with the transactivation data shown in Fig.1A , and suggests again that the nTRE is responsible for receptor binding and regulation of GH promoter activity in non-pituitary cells.
This was confirmed by the finding that TRα bound strongly to the minimal GH promoter that contains only the nTRE. Again, promoter occupancy was observed only with the unliganded receptor, and T3 inhibited binding.
Unliganded TR causes recruitment of acetylated histone H3 to the minimal GH promoter-It has
been proposed that ligand-independent transcriptional stimulation by TR is associated with increased histone acetylation (22) and that ligand-induced recruitment of a HDAC is involved in Similar results were obtained with butyrate, other deacetylase inhibitor (data not shown). In addition, expression of HDAC1 decreased strongly stimulation by the unoccupied receptor, and consequently also reduced T3-dependent repression (Fig.3B) . This effect appears to be specific, because expression of the deacetylase did not affect basal promoter activity.
These results strongly suggest that histone acetylation is involved in stimulation of transcription Furthermore, these factors did not appear to compete for in vivo binding to the promoter, as association of TR and TBP was not decreased when both factors were expressed together.
Therefore, the receptors and TBP can form a ternary complex on the GH promoter, which may be facilitated by the existence of direct protein to protein interaction between these factors (27).
During the formation of the PIC, several other basal factors interact with TBP and stabilize binding of TFIID. We then tested by gel retardation assays, whether accessibility of TFIIB and TFIIA to the GH promoter was altered by the presence of the receptor heterodimer. As shown in 
The AF2 domain is dispensable for synergism of TR and TBP, but is required for the reversal of
stimulation by thyroid hormone-To establish whether mutations that diminish or abolish T3-dependent transactivation also affected the ability of the receptor to cooperate with TBP, different chimeras of the v-erbA oncogene, which is the viral counterpart of TRα, the c-erbA protooncogene, were used (Fig.7) . TBP cooperated strongly with construct C1, an otherwise wildtype TRα containing the C-terminus of v-erbA, in the absence of ligand. However, in contrast with the results obtained with the wild type receptor, no significant reversal of stimulation upon incubation with T3 was found in cells expressing this mutant. Conversely, the V1 chimera, in which the C-terminus of TRα containing the AF2 domain has been introduced in the v-erbA background was able not only to display constitutive activity and synergism with TBP, but also gained the ability to mediate T3-dependent repression of promoter activity. Other TRα/v-erbA chimeras shown in Fig.3 were able to cooperate with TBP with potency similar to that shown by the native receptor. However, T3 only repressed activity in cells transfected with constructs that possess the TRα C-terminal region.
Above results suggested that helix 12 of the LBD, which contains the core AF2 domain, is dispensable for ligand-independent stimulation and cooperation with TBP, although it appears to be required for ligand-dependent repression. To further analyze the role of the AF2 domain, the influence of mutation of a conserved glutamic acid residue in helix 12, which is required for binding of coactivators and ligand-dependent transcriptional activation, was also examined. In addition, the effect of this mutation was compared with that caused by mutation of a conserved lysine residue in helix 3. Both residues form a "charge clamp" that positions the LXXLL motif of the coactivators into the hydrophobic pocket formed by the surfaces of receptor helices 3, 5 and 6 (3). As shown in Fig.8A , mutants E401K and E401Q, were able to synergize with TBP to stimulate the core GH promoter with a potency similar to that shown by the native receptor.
However, the stimulation was not inhibited by T3 in cells expressing the mutant receptors. The lack of ability to supress does not correlate with a reduced ability to bind ligand. E401Q binds T3
with a normal affinity (Kd of 0.1 nM), and although the E401K mutant shows a decreased affinity with a Kd of 3.3 nM (4), T3 was used in the experiments at a 100 nM, a high enough concentration to occupy the receptor. In contrast with the results obtained with the helix 12 mutants, K232I mutant in helix 3 was unable to cooperate with TBP to stimulate the promoter.
Furthermore, promoter activity was consistently lower in cells expressing the combination of TBP and the mutant receptor than in cells expressing TBP alone.
One possible explanation for the lack of stimulatory effect of the K232I receptor could be the inability of this mutant to interact with TBP. However, a normal interaction of the helix 3 mutant with TBP could be observed. As shown in Fig.8B , not only TRα and the helix 12 mutants E401K
and C1, but also the mutant K232I efficiently bound TBP in in vitro GST pull-down assays. This interaction mapped to the C-terminal domain of TBP, as the different receptors failed to interact specifically with the N-terminal portion of TBP (aa 1-167) whereas they associated with the Cterminus of this factor (aa 95-339).
A mutation of TR that reduces corepressor binding affects stimulation of the basal GH
promoter and synergism with TBP-It has been recently shown that mutation of the conserved lysine residue in helix 3 also impairs interaction of corepressors with the receptors (37-39).
Therefore, we also examined the influence of other mutant receptor defective in interaction with corepressors on GH promoter activity. This receptor, the AHT mutant, has a 3 aminoacids substitution in the so called CoR box located in helix 1 of the LBD (10). The AHT mutation has been introduced in the background of the TRβ gene and abolishes binding of corepressors. As shown in Fig.9A , wild-type TRβ also caused a ligand-independent activation and cooperated with TBP to stimulate the promoter. The synergism between TRβ and TBP was also reversed in the presence of T3. In contrast, the unliganded AHT mutant was unable to stimulate the promoter and did not cooperate with TBP.
In view of the finding that the mutant receptors K232I and AHT that are defective for corepressor binding are unable to stimulate the promoter, the influence of expression of the corepressors on promoter activity was also analyzed. As shown in heterodimer to the nTRE could also result in recruitment of the PIC complex to the GH promoter that contains the negative element. This is based not only on in vitro binding studies, but also on functional studies in which we observe a strong synergism between unoccupied TR and TBP.
These results show that TBP is limiting for TR-activated transcription of this minimal promoter.
Potentiation of activation by unliganded receptors has not been previously reported, but in other study has been shown that ligand-dependent activation of simple promoters consisting of an estrogen response element and a TATA box can be enhanced in response to over-expression of TBP (29). Although this potentiation appears to be independent of spacing between the estrogen response element and the TATA box, the influence of overlapping elements for the estrogen receptor and TBP has not been examined.
We have previously reported that ligand-independent activation of the core GH promoter by TR does not require the receptor AF2 helix (19) . Our present results demonstrate that helix 12 is also dispensable for synergism of the unoccupied receptor with TBP. Since the AF2 motif is required for coactivator recruitment, these results suggest that they do not play an important role in constitutive activation by TR. In contrast, the AF2 domain appears to be important in mediating ligand-dependent repression. This is based in the finding that T3 reversed the synergistic actions of TR and TBP on the promoter, but this effect was abolished in TRs in which helix 12 of the LBD is deleted, or mutated in a conserved glutamic acid residue critical for binding of coactivators. These results were confirmed with the use of TRα/v-erbA chimeras lacking the AF2 helix, which were able to increase basal promoter activity and to cooperate with TBP, but were unable to mediate ligand-dependent reversion of this stimulation.
In contrast with the results obtained with helix 12 AF2 mutants, mutation of a conserved residue in helix 3 of the LBD renders a receptor that was unable both to mediate a constitutive T3-independent activation of the core GH promoter (19) , and to cooperate with TBP to enhance promoter activation. This receptor interacts normally with TBP, showing that the direct interaction between TR and TBP is not sufficient for the synergism between both factors. The lysine residue in helix 3 of TR was originally demonstrated to be critical for coactivator recruitment (46, 47) .
However, more recent observations have suggested an additional role for this residue in binding of corepressors. Interestingly, corepressors possess a motif similar to the signature LXXLL motif in coactivator proteins, which is sufficient for corepressor binding and ligand-induced release.
This allows binding of coactivators and corepressors to partially overlapping binding sites in the receptor. Accordingly, aminoacids of helixes 3, 5 and 6, among them the conserved K232
residue, that directly participate in coactivator binding are also involved in corepressor association (48) (49) (50) . That corepressors could participate in T3-independent activation of the GH promoter is further suggested by the finding that a TRβ mutant in the CoR box was also unable to constitutively activate the promoter and to synergize with TBP. Although this mutation also appears to affect overall structure of the receptor LBD (51), the mutated residues in the CoR box are essential for interaction of receptors with the corepressors (9,10). It has been described that overexpression of NCoR or SMRT paradoxically enhances rather than supresses basal activation of the thyroid-stimulating hormone α (TSHα) and thyrotropin releasing hormone (TRH)
promoters by unliganded TR (20) . However, we find that expression of corepressors has little effect on the stimulation of the basal GH promoter by unliganded receptor and that, furthermore, it does not enhance the synergism with TBP. A different promoter context and/or cell-specific effects could explain these differences.
In summary, our results show an important role of the nTRE on the regulation of GH promoter activity by TR. Binding of unliganded TR to this element causes a paradoxical stimulation that is associated with recruitment of acetylated histones to the promoter. CAT activity was determined in cells treated during 48 h with T3. 
